Are Endovascular Interventions for Central Vein Obstructions due to Cardiac Implanted Electronic Devices Effective?

• Published in: Frontiers in surgery Vol. 5; p. 49
• Main Authors: Sotiriadis, Charalampos, Volpi, Stephanie, Douek, Pauline, Chouiter, Amine, Muller, Olivier, Qanadli, Salah D
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 30-07-2018
• Subjects: angioplasty; central venous occlusion; CIED; lead exchange; stenting; Surgery; CIED; lead exchange; central venous occlusion; angioplasty; stenting
• ISSN: 2296-875X; 2296-875X
• DOI: 10.3389/fsurg.2018.00049

One of the late-onset complications of cardiac implanted electronic devices (CIEDs) is central venous obstruction (CVO). The aim of this study was to investigate the feasibility, efficacy, and safety of endovascular treatment of CIED-related CVOs.
Eighteen patients who underwent endovascular management of their device-related CVO were reviewed. Patients were classified into three groups: Group I patients were asymptomatic and needed lead replacement; Group II patients presented with symptomatic CVO without lead dysfunction, and Group III patients were referred with both symptomatic CVO and lead dysfunction. A treatment strategy involved recanalization and balloon angioplasty for Group I and angioplasty/stents for Groups II and III. Technical success, clinical success, complications, and long-term follow-up were assessed.
Thirteen patients were in Group I, four in Group II, and one in Group III. Technical and clinical success was achieved in 17 patients (94%). No major complications were reported. Restenosis was observed in two patients at 40 and 42 weeks of follow-up, and these patients were successfully treated with angioplasty.
Endovascular management of CVO due to CIED is a safe and efficient technique. Plain balloon angioplasty is sufficient for lead replacement purposes, while stenting is needed for symptomatic CVO to achieve good long-term patency.